The outcome of regulatory inspections is critical to an organization’s success. The FDA performs inspections to check that companies are maintaining compliance with applicable regulations and quality standards. Though you do your best to avoid it, receiving a 483 or Warning Letter is inevitable. It’s important to take the observations very seriously because you only have 15 days to submit the subsequent responses.
But ensuring that you are aware and understand what the regulatory agency is expecting in the response can be a challenge. What should you include? What are the risks of not submitting an appropriate response?
This 90-minute course will discuss the importance of developing and submitting a robust, timely response to FDA 483 observations or warning letters; as well as, educate the audience on the essential elements of a thorough response. Additionally, this course will review the proper structure of the response to ensure the regulatory agency’s expectations are met and the submission process.
LEARNING OBJECTIVES
At the completion of this session, you will be able to:
- Identify timelines and potential regulatory outcomes of not submitting an appropriate response
- Review the components necessary to develop a thorough response
- Utilize a response checklist
- Evaluate recent Regulatory observations and review associated responses
- Recognize the process for submitting the response to the regulatory agency
- Discuss when and how to provide follow-up updates to the regulatory agency post the initial response
- Develop post-response outcomes
WHO WILL BENEFIT?
This course will be valuable to anyone engaged in the development, manufacturing, sale, or distribution of FDA-regulated healthcare products. Additionally, this course will provide a good primer for those involved in writing observation responses. This includes personnel in:
- Quality
- Manufacturing
- Engineering
At the completion of this session, you will be able to:
- Identify timelines and potential regulatory outcomes of not submitting an appropriate response
- Review the components necessary to develop a thorough response
- Utilize a response checklist
- Evaluate recent Regulatory observations and review associated responses
- Recognize the process for submitting the response to the regulatory agency
- Discuss when and how to provide follow-up updates to the regulatory agency post the initial response
- Develop post-response outcomes
This course will be valuable to anyone engaged in the development, manufacturing, sale, or distribution of FDA-regulated healthcare products. Additionally, this course will provide a good primer for those involved in writing observation responses. This includes personnel in:
- Quality
- Manufacturing
- Engineering
Speaker Profile
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Upcoming Webinars
How to Write Contracts for Procurement Professionals
How to Deal with Employees Who Love to Argue and Debate Eve…
Project Management for administrative professionals
Sunshine Act Reporting - Clarification for Clinical Research
Onboarding Best Practices for 2025: Proven Strategies to Po…
Transform Data into Insights: A Beginners Guide to Excel Pi…
Reprogramming your mind for Corporate Excellence: 4 Steps t…
Terminating Toxicity: Strategies For Leaders To Confidently…
ChatGPT and Project Management: Leveraging AI for Project M…
Uplifting the Credibility of HR: How to Build the Credibili…
How to Manage the Legal Landmine of the FMLA, ADA and Worke…
How to Write Effective Audit Observations: The Principles f…
Strategic Interviewing & Selection: Getting the Right Talen…
Onboarding Best Practices for Millennial and All Employees
Performance of Root Cause Analysis, CAPA, and Effectiveness…
Bridging Generational Divides in the Workplace
Emotional Intelligence: Mastering the Emotions of Great Lea…
FDA Audit Best Practices - Do's and Don'ts
2-Hour Virtual Seminar on How to Conduct an Internal Harass…
Accounting For Non Accountants : Debit, Credits And Financi…
Successful Strategies for FDA Expedited Pathways for Your D…
Regulation update Q1 2025: New and Proposed Regulations for…
Unlock Employee Loyalty: Stay Interviews Will Keep Them Eng…
Pay Transparency in Action: Strategies for Building Trust a…
Designing Employee Experiences to Build a Culture of Compli…
Reinvent Your Business with the Power of AI
Excel Lookup Functions: VLOOKUP, HLOOKUP, and XLOOKUP Made …
Developing and Implementing Quality Culture in the Organiza…
Tips and Techniques for Conducting an Effective Fraud Risk …
Break Free from Toxicity: Reclaim Your Power and Peace
Physician Employment Agreements: Problem Areas that can be …
Measure the Effectiveness of Compliance Programs by Engagin…
FDA Regulation of Artificial Intelligence/ Machine Learning
Quality Management Systems and Data Integrity
Implementing an Effective Human Error Reduction Program
Navigating 2025 Employment Laws: What Every Employer Needs …
Cleaning Data without Complex Functions - A Course for Data…
Succession Plan for 2025: It's Not Just for Emergencies - I…
Employers Should Prepare for Immigration Raids in 2025! Thi…
Managing Toxic Employees: Strategies For Leaders To Effecti…
Using High-Performance Coaching for Managers to Address Per…